Ramirez, April Rose D.

HRN: 11-95-32  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2023
CEFUROXIME 500MG (TAB)
10/14/2023
10/21/2023
PO
500 Mg
BID
Thickly MSAF
Waiting Final Action 
10/14/2023
METRONIDAZOLE 500MG (TAB)
10/14/2023
10/21/2023
PO
500 Mg
TID
Thickly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: